SINGLETON J MATTHEW sold 52.0% of their position (10.30K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $715.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/20/2024ACC: 0000950170-24-108577
Director
Since Jan 2019
-10.30K
Net shares
Net seller
$715.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.30K acquired · 20.60K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+10.30K
Price / share
$1.19
Trade value
$12.26K
% of position
108.4%
9/20/2024
9.50K→19.80K
Common Stock, par value $0.00001 per share
Direct
Shares
−10.30K
Price / share
$69.50
Trade value
$715.85K
% of position
52.0%
9/20/2024
19.80K→9.50K
Total
Net shares
+0.00
Net value
-$703.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 9/20/2024 | M · Option Exercise | +10.30K | $1.19 | $12.26K | 108.4% | 9.50K | 19.80K |
| Common Stock, par value $0.00001 per share Direct | 9/20/2024 | S · Sale | −10.30K | $69.50 | $715.85K | 52.0% | 19.80K | 9.50K |
| Total | +0.00 | -$703.59K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10.30K shares
Shares
−10.30K
Strike price
1.19
Held after
0.00
Exercisable
—
9/20/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10.30K shares | 9/20/2024 | M · Option Exercise | −10.30K | 1.19 | — | 0.00 |